Manabu Morimoto

3PUBLICATIONS
19CO-AUTHORS
Biomedical imagingCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|Jan 05, 2023
Cabozantinib in Japanese patients with advanced hepatocellular carcinoma: Final results of a multicenter phase II study.

Naoya Kato, Masatoshi Kudo, Kaoru Tsuchiya

|Jan 24, 2022
Comparative study between sorafenib and lenvatinib as the first-line therapy in the sequential treatment of unresectable hepatocellular carcinoma in a real-world setting.

Taito Fukushima, Manabu Morimoto, Makoto Ueno

Pageof 1